Filing Flows

Filing Flows › Companies › Omada Health › Report card

Omada Health earnings report card

Every report on file against what analysts and the company itself expected, and what the stock did

Beat rate5 of 5 reports beat the EPS estimate

Omada Health (OMDA) beat the analysts' EPS estimate in 5 of its last 5 reports (100%), by +158.9% on average.

Beat rate100% of 5
Average surprise+158.9%

Report by report

QuarterReportedEPS est.EPS reportedSurpriseRevenue reported
Q3 2026Nov 5, 2026$0.10$0.21+114.3%$91.3M
Q2 2026Aug 6, 2026$0.06$0.20+219.8%$87.8M
Q1 2026May 7, 2026−$0.04$0.05n/m$78.0M
Q4 2025Mar 5, 2026$0.03$0.16n/m$75.8M
Q3 2025Nov 6, 2025−$0.07$0.03+142.6%$68.0M

Estimates and reported EPS are the Street's adjusted figures. Revenue reported is from the company's filing. No daily prices are on file for these report days, so the stock's moves are not shown.

Charts

Omada Health: EPS reported against the estimateOmada Health: EPS reported against the estimateEstimateReported−$0.07$0.03Q3 2025$0.03$0.16Q4 2025−$0.04$0.05Q1 2026$0.06$0.20Q2 2026$0.10$0.21Q3 2026
Latest (Q3 2026): Estimate $0.10, Reported $0.21.

The next report: what to expect → Omada Health: every quarter →

Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.